Stocks and Investing
Stocks and Investing
Fri, February 23, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Eric Joseph Maintained (VIR) at Hold with Increased Target to $10 on, Feb 23rd, 2024
Eric Joseph of JP Morgan, Maintained "Vir Biotechnology, Inc." (VIR) at Hold with Increased Target from $9 to $10 on, Feb 23rd, 2024.
Eric has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Eric's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Eric
- Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, February 14th, 2024
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $15 on, Friday, November 3rd, 2023
Contributing Sources